Identification Module
The Identification Module contains basic identifying information about the clinical trial, including the NCT ID, brief title, official title, acronym, organization study ID information, and organization details. This module provides essential identifiers for the trial.
Identification Module path is as follows:
Study -> Protocol Section -> Identification Module
Identification Module
Ignite Creation Date:
2025-12-25 @ 5:00 AM
Ignite Modification Date:
2025-12-25 @ 5:00 AM
NCT ID:
NCT01203618
Brief Title:
Exploratory Study of Farletuzumab to Treat Resectable, Non-functioning Pituitary Adenomas
Official Title:
Exploratory Phase 2 Study of Farletuzumab in Resectable Non-functioning Pituitary Adenoma
Study:
NCT01203618
Protocol Section:
NCT01203618